Your browser doesn't support javascript.
loading
Model learning to identify systemic regulators of the peripheral circadian clock.
Martinelli, Julien; Dulong, Sandrine; Li, Xiao-Mei; Teboul, Michèle; Soliman, Sylvain; Lévi, Francis; Fages, François; Ballesta, Annabelle.
Afiliação
  • Martinelli J; INSERM UMR-S 900, Institut Curie, MINES ParisTech CBIO, PSL Research University, 92210 Saint-Cloud, France.
  • Dulong S; Lifeware Group, Inria Saclay Ile-de-France, Palaiseau 91120, France.
  • Li XM; UPR "Chronotherapy, Cancers and Transplantation", Paris-Saclay University, Faculty of Medicine Kremlin Bicêtre, Le Kremlin Bicêtre, 94270, France.
  • Teboul M; UPR "Chronotherapy, Cancers and Transplantation", Paris-Saclay University, Faculty of Medicine Kremlin Bicêtre, Le Kremlin Bicêtre, 94270, France.
  • Soliman S; Côte d'Azur University, CNRS, INSERM, iBV, Nice 06000, France.
  • Lévi F; Lifeware Group, Inria Saclay Ile-de-France, Palaiseau 91120, France.
  • Fages F; UPR "Chronotherapy, Cancers and Transplantation", Paris-Saclay University, Faculty of Medicine Kremlin Bicêtre, Le Kremlin Bicêtre, 94270, France.
  • Ballesta A; Hepato-Biliary Center, Paul-Brousse Hospital, Assistance Publique-Hôpitaux de Paris, Villejuif 94800, France.
Bioinformatics ; 37(Suppl_1): i401-i409, 2021 07 12.
Article em En | MEDLINE | ID: mdl-34252929
ABSTRACT
MOTIVATION Personalized medicine aims at providing patient-tailored therapeutics based on multi-type data toward improved treatment outcomes. Chronotherapy that consists in adapting drug administration to the patient's circadian rhythms may be improved by such approach. Recent clinical studies demonstrated large variability in patients' circadian coordination and optimal drug timing. Consequently, new eHealth platforms allow the monitoring of circadian biomarkers in individual patients through wearable technologies (rest-activity, body temperature), blood or salivary samples (melatonin, cortisol) and daily questionnaires (food intake, symptoms). A current clinical challenge involves designing a methodology predicting from circadian biomarkers the patient peripheral circadian clocks and associated optimal drug timing. The mammalian circadian timing system being largely conserved between mouse and humans yet with phase opposition, the study was developed using available mouse datasets.

RESULTS:

We investigated at the molecular scale the influence of systemic regulators (e.g. temperature, hormones) on peripheral clocks, through a model learning approach involving systems biology models based on ordinary differential equations. Using as prior knowledge our existing circadian clock model, we derived an approximation for the action of systemic regulators on the expression of three core-clock genes Bmal1, Per2 and Rev-Erbα. These time profiles were then fitted with a population of models, based on linear regression. Best models involved a modulation of either Bmal1 or Per2 transcription most likely by temperature or nutrient exposure cycles. This agreed with biological knowledge on temperature-dependent control of Per2 transcription. The strengths of systemic regulations were found to be significantly different according to mouse sex and genetic background. AVAILABILITY AND IMPLEMENTATION https//gitlab.inria.fr/julmarti/model-learning-mb21eccb. SUPPLEMENTARY INFORMATION Supplementary data are available at Bioinformatics online.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relógios Circadianos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Relógios Circadianos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article